Cancer Research Institute (CRI) shared on LinkedIn:
“CICON24 promises to be an unmissable event for anyone interested in advancing cancer immunotherapy. Submit an abstract by June 3, and be part of the conversation shaping the future of cancer treatment! All abstracts will be considered for short oral presentations. Don’t miss this opportunity.”